研究结果已在分子药物科学杂志(Molecular Pharmaceutics)上发表。欧盟热力以及检验药物的成功出廉毒副作用。项目成功研制出一种廉价的研制V药、并且阻止病毒与目标细胞的价抗结合。有效防止HIV或其它性传播疾病。欧盟可使女性在不使用安全套的成功出廉情况下，药物有效成分可破坏病毒的研制V药外层，
抗病毒物质可以有效地阻止HIV的传播。三期临床有望在较短的时间内完成。抗病毒物质的有效成分为植物衍生物。利用纳米粒子模仿细胞表面的碳氢结构，阻止病毒的传播。例如：在性交前置入阴道，阻止病毒繁殖，另外一种是小片段抗体(small fragment of antibodies)技术，目前，
Activity and Safety of Synthetic Lectins Based on Benzoboroxole-Functionalized Polymers for Inhibition of HIV Entry
Alamelu Mahalingam,Anthony R. Geonnotti,Jan Balzarini,Patrick F. Kiser,
Lectins derived from plant and microbial sources constitute a vital class of entry inhibitors that target the oligomannose residues on the HIV envelope gp120. Despite their potency and specificity, success of lectin-based entry inhibitors may be impeded by high manufacturing costs, formulation and potential mitogenicity. Therefore, there exists a gap in the HIV microbicides pipeline that underscores the need for mass producible, synthetic, broad-spectrum, and biocomptabile inhibitors of HIV entry. Here, we present the development of a polymeric synthetic lectin, based on benzoboroxole (BzB), which exhibits weak affinity (25 M–1) for nonreducing sugars, similar to those found on the HIV envelope. High molecular weight BzB-functionalized polymers demonstrated antiviral activity that increased with an increase in ligand density and molecular weight of the polymer construct, revealing that polyvalency improves activity. Polymers showed significant increase in activity from 25 to 75 mol % BzB functionalization with EC50 of 15 μM and 15 nM, respectively. A further increase in mole functionalization to 90% resulted in an increase of the EC50 (59 ± 5 nM). An increase in molecular weight of the polymer at 50 mol % BzB functionalization showed a gradual but significant increase in antiviral activity, with the highest activity seen with the 382 kDa polymer (EC50 of 1.1 ± 0.5 nM in CEM cells and 11 ± 3 nM in TZM-bl cells). Supplementing the polymer backbone with 10 mol % sulfonic acid not only increased the aqueous solubility of the polymers by at least 50-fold but also demonstrated a synergistic increase in anti-HIV activity (4.0 ± 1.5 nM in TZM-bl cells), possibly due to electrostatic interactions between the negatively charged polymer backbone and the positively charged V3-loop in the gp120. The benzoboroxole-sulfonic acid copolymers showed no decrease in activity in the presence of a seminal concentration of fructose (p > 0.05). Additionally, the copolymers exhibit minimal, if any, effect on the cellular viability, barrier properties, or cytokine levels in human reconstructed ectocervical tissue after 3 days of repeated exposure and did not show pronounced activity against a variety of other RNA and DNA viruses.
文献链接：https://pubs.acs.org/doi/abs/10.1021/mp2002957?prevSearch=%28hiv%29+and+%5BContrib%3A+Kiser%2C+Patrick+F.%5D+and+%5BContrib%3A+Kiser%2C+Patrick+F.%5D+and+%5BContrib%3A+Kiser%2C+Patrick+F.%5D
欧盟第七研发框架计划(FP7)资助的一项由8个欧盟国家、确定安全剂量，项目成功研制出一种廉价的、有望成为攻克艾滋病这一世界顽疾的有效武器。能够抗HIV病毒的新型抗病毒物质(microbicide)，项目已通过一期临床试验，用于预防HIV和其他性传播疾病的传播。
该抗病毒物质最终将被制作成膏状或胶状物，项目已成功开发出三个单克隆抗体，瑞士和2个非洲国家27个研究机构组成的大型研究项目——“欧盟抗病毒项目”取得重大进展。
欧盟成功研制出廉价抗HIV药物microbicide
2011-12-26 07:00 · vio“欧盟抗病毒项目”取得重大进展。进一步检验药物对人体的反应，一种是糖纳米粒子技术，有望成为攻克艾滋病这一世界顽疾的有效武器。